Global Medical Director, Riliprubart

Role Summary

Global Medical Director for riliprubart responsible for co-developing and leading the medical strategy across the product value chain, overseeing medical affairs studies, and coordinating with evidence generation, external stakeholders, and Scientific Communications to advance the therapeutic landscape for CIDP and riliprubart.

Responsibilities

• Co-develop, plan and lead the execution of the medical strategy for riliprubart across the product value chain.
• Co-create the IEGP strategy with Medical Evidence Generation Lead and other evidence generation-related functions: CSU, RWE, HEVA, MO&E and country teams.
• Lead the execution of assigned medical affairs studies. Provide input in design, monitoring, analysis, and communication of the assigned studies. Serve as a global medical point of contact for such studies for internal and external stakeholders.
• Oversee insight generation plan and input to the assigned assets overall medical strategy.
• Provide strategic input to Scientific Communications team to plan and execute evidence dissemination and medical education plans.
• Build trust with Global external stakeholders to advance their understanding of the therapeutic area and evolve the treatment landscapes for CIDP and riliprubart.
• Oversee the design of medical programs/initiatives to drive the therapeutic value of riliprubart and address unmet medical needs (i.e., MAPs, PSP, Diagnostic support programs, CSRs, etc)
• Oversee the adherence to allocated budgets, plan and execute activities aligned with strategy and smart execution principles to assure prioritization and cross-functional alignment.
• Accountable for medical affairs review and scientific integrity of internal and external medical materials.

Qualifications

• Deep expertise in Neurology & Neuromuscular Diseases, preferred.
• Minimum of 4 years’ experience in relevant Medical Affairs
• Demonstrated industry experience working in strategic roles from medical affairs or clinical development related areas including scientific KOL engagement, evidence generation and scientific communication at Global and Key Market level, preferred.
• Broad drug development experience with robust knowledge of regulatory, market access and reimbursement.
• Demonstrated experience in managing clinical trials in a pharmaceutical environment is strongly desired.
• Demonstrated specialty care product launch experience at a country level, strongly preferred.
• Significant line and matrix management experience, including strong transversal collaboration with key functions such as Research, Clinical Development, Commercial, Health Economics, Value and Access and Product Management functions.

Skills

• Strategic thinking and ability to disrupt the status quo with innovation while remaining pragmatic.
• Result orientation with ability to develop and execute strategies and adapt to ambiguity.
• People leadership with ability to coach, provide feedback, and support cross-functional teams.
• Relationship building and influence; effective stakeholder management.
• Highest ethical, regulatory and scientific standards.

Education

• Education: Doctorate in relevant scientific discipline or Pharmacy – Medical Degree preferred
• Languages: Fluent in English